(R)-((1S,2S,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol hydrobromide xhydrate

Catalog No. :
ACFRDJ143
CAS No. :
207386-86-5
Molecular Formula :
C20H29BrN2O3
Molecular Weight :
425.37

IUPAC Name:(R)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol hydrobromide hydrate

(R)-((1S,2S,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol hydrobromide xhydrate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g98%$147.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(R)-((1S,2S,4S,5R)-5-Ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol hydrobromide xhydrate
IUPAC Name(R)-((1S,2S,4S,5R)-5-ethylquinuclidin-2-yl)(6-methoxyquinolin-4-yl)methanol hydrobromide hydrate
MDL No.MFCD06656066
Molecular FormulaC20H29BrN2O3
Molecular Weight425.37
SMILESBr.CC[C@H]1C[N@@]2CC[C@H]1C[C@H]2[C@H](O)C1=C2C=C(OC)C=CC2=NC=C1.O
InChI KeyIWSVSZYIGVGHCN-HZQSTTLBSA-N
Synonym(1S,2R)-(+)-2-AMINOCYCLOHEX-4-ENECARBOXYLIC ACID HYDROCHLORIDE;Dihydroquinine hydrobromide hydrate,99%;DIHYDROQUININE HYDROBROMIDE HYDRATE;Hydroquinine hydrate hydrobromide;(8α,9R)-10,11-dihydro-6′-methoxycinchonan-9-ol hydrobromide hydrate
CAS No.207386-86-5

Synthetic Route by SureRoute

1. ACFRDJ143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9 In Stock
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACFRDJ143 route product structure diagram
    ACFRDJ143207386-86-5
Inquiry

2. ACFRDJ143 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACFRDJ143 route product structure diagram
    ACFRDJ143207386-86-5
Inquiry

Comments (0)